Lead sponsor
University of Cincinnati
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
1
Trials led
0
Active
54
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
1
Trials by status
Completed
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese AdultsBMI ≥30Ph 4Completed54